North America Large And Small-scale Bioprocessing Market Size, Share & Industry Trends Analysis Report By Scale, By Use Type, By Mode (In-house, and Outsourced), By Application, By Workflow, By Product, By Country and Growth Forecast, 2023 - 2030

The North America Large And Small-scale Bioprocessing Market would witness market growth of 13.4% CAGR during the forecast period (2023-2030).

Large-scale bioprocessing continues to be driven primarily by the production of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. This trend is likely to persist as the demand for biologics remains high. The adoption of single-use bioprocessing technologies is increasing in large-scale bioprocessing. Single-use systems offer flexibility, reduce the risk of cross-contamination, and lower operational costs compared to traditional stainless-steel systems. There is a growing interest in continuous bioprocessing as it provides improved process control, reduced production costs, and faster time-to-market.

Miniaturization of bioprocessing equipment and the use of microfluidic devices are gaining traction in small-scale bioprocessing. These technologies enable rapid prototyping and experimentation. Small-scale bioprocessing is essential for developing and manufacturing cell and gene therapies, which have grown tremendously in recent years. Small-scale bioprocessing is particularly suited for customized and personalized medicine approaches, allowing for tailored treatments based on individual patient needs. Small-scale bioprocessing is widely used in academic and research labs for bioprocess development and optimization, and this trend is expected to continue.

North America is a thriving hub for the market, with a diverse and dynamic ecosystem encompassing pharmaceutical giants, biotech startups, academic research, and contract service providers. This diversity and innovation continue to drive advancements in bioprocessing technologies and contribute to the growth of the biopharmaceutical industry in the region. Due to these aspects, the market will grow in upcoming years.

The US market dominated the North America Large And Small-scale Bioprocessing Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $39,322.4 million by 2030. The Canada market is registering a CAGR of 16% during (2023 - 2030). Additionally, The Mexico market would showcase a CAGR of 15% during (2023 - 2030).

Based on Scale, the market is segmented into Industrial Scale, and Small Scale. Based on Use Type, the market is segmented into Multi Use, and Single Use. Based on Mode, the market is segmented into In-house, and Outsourced. Based on Application, the market is segmented into Biopharmaceuticals, Speciality Industrial Chemicals, and Environmental Aids. Based on Workflow, the market is segmented into Industrial Downstream Processing, Fermentation, and Upstream Processing. Based on Product, the market is segmented into Bioreactors/Fermenters, Cell Culture Products, Filtration Assemblies, Bioreactors Accessories, Bags & Containers, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck KGaA, Thermo Fisher Scientific, Inc., GE healthcare, Corning Incorporated, Sartorius AG, Lonza Group AG (Capsugel), Meissner Filtration Products, Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd. and Eppendorf SE.

Scope of the Study

Market Segments Covered in the Report:

By Scale

• Industrial Scale
• Small Scale

By Use Type

• Multi Use
• Single Use

By Mode

• In-house
• Outsourced

By Application

• Biopharmaceuticals
• Speciality Industrial Chemicals
• Environmental Aids

By Workflow

• Downstream Processing
• Fermentation
• Upstream Processing

By Product

• Bioreactors/Fermenters
• Cell Culture Products
• Filtration Assemblies
• Bioreactors Accessories
• Bags & Containers
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• Merck KGaA
• Thermo Fisher Scientific, Inc.
• GE healthcare
• Corning Incorporated
• Sartorius AG
• Lonza Group AG (Capsugel)
• Meissner Filtration Products, Inc.
• Boehringer Ingelheim International GmbH
• F.Hoffmann-La Roche Ltd.
• Eppendorf SE

Unique Offerings

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free